KhalilMTeunissenCELehmannS, et al. Neurofilaments as biomarkers in neurological disorders – towards clinical application. Nat Rev Neurol2024; 20(5): 269–287.
2.
KuhleJKropshoferHHaeringDA, et al. Blood neurofilament light chain as a biomarker of MS disease activity and treatment response. Neurology2019; 92: e1007–e1015.
3.
Bar-OrANicholasJFengJ, et al. Exploring the clinical utility of neurofilament light chain assays in multiple sclerosis management. Neurol Neuroimmunol Neuroinflamm2025; 12(4): e200427.
4.
BenkertPMeierSSchaedelinS, et al. Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: A restrospective modelling and validation study. Lancet Neurol2022; 21: 246–257.
5.
FoxRJCreeBACde SézeJ, et al. Temporal relationship between serum neurofilament light chain and radiologic disease activity in patients with multiple sclerosis. Neurology2024; 102: e209357.
